Yehuda Zelig
Vorstandsvorsitzender bei Scigen (I.L.) Ltd.
Profil
Yehuda Zelig is the founder of Valin Technologies Ltd.
He currently holds positions as Managing Director at Scigen (I.L.) Ltd., Director at Active P Ltd., and Senior Vice President at Biorest Ltd.
Previously, he held positions as Director at SciSparc Ltd.
and Vice President-Manufacturing & Scale Up at Biotechnology General (Israel) Ltd.
Mr. Zelig obtained an undergraduate degree from The Hebrew University of Jerusalem and an MBA from Technion Institute.
Aktive Positionen von Yehuda Zelig
| Unternehmen | Position | Beginn |
|---|---|---|
Scigen (I.L.) Ltd.
 Scigen (I.L.) Ltd. Pharmaceuticals: MajorHealth Technology Part of FDS Pharma LLP, Scigen (I.L.) Ltd. is an Israeli company that manufactures vaccines. The company is based in Rehovot, Israel. The CEO of the company is Yehuda Zelig. Scigen (I.L. was acquired by FDS Pharma LLP from SciGen Pte Ltd. on February 14, 2012 for $2 million. | Vorstandsvorsitzender | 25.02.2010 |
| Biorest Ltd. | Corporate Officer/Principal | 25.02.2010 |
Active P Ltd.
 Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Direktor/Vorstandsmitglied | 03.03.2010 |
| Valin Technologies Ltd. | Gründer | - |
Ehemalige bekannte Positionen von Yehuda Zelig
| Unternehmen | Position | Ende |
|---|---|---|
Biotechnology General (Israel) Ltd.
 Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | - |
| SCISPARC LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Yehuda Zelig
| Technion Institute | Masters Business Admin |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCISPARC LTD. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Scigen (I.L.) Ltd.
Scigen (I.L.) Ltd. Pharmaceuticals: MajorHealth Technology Part of FDS Pharma LLP, Scigen (I.L.) Ltd. is an Israeli company that manufactures vaccines. The company is based in Rehovot, Israel. The CEO of the company is Yehuda Zelig. Scigen (I.L. was acquired by FDS Pharma LLP from SciGen Pte Ltd. on February 14, 2012 for $2 million. | Health Technology |
| Biorest Ltd. | |
Active P Ltd.
Active P Ltd. Pharmaceuticals: MajorHealth Technology Active P Ltd. develops proprietary oral available peptide drugs to treat diabetes. The company was founded by Shmulik Hess, Chaim Gilon, and Amnon Hoffman on September 10, 2008 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
| Valin Technologies Ltd. |
